Example: Heart Attack

Search clinical trials for: Estropipate

Total 24 results

NCT00449202

Unknown status

Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)

Conditions: Obesity
NCT00449254

Unknown status

Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults

Conditions: Obesity
NCT00623116

Enrolling by invitation

A Study to Characterize Epidemiology, Clinical and Genetic Features of Kallmann Syndrome in Finland

Conditions: Kallmann Syndrome
NCT03258307

Completed

Comparison of Perilipin, Leptin, Adipolipin, Adiponectin, Resistin, Visfatin, Estrone Levels Pre-post Omentectomy

Conditions: Gynecologic Cancer
NCT00866437

Unknown status

Evaluation of Efficacy/Safety of EVE-PMS Skin Test Panel

Conditions: Premenstrual Syndrome
NCT00873262

Unknown status

Evaluation of Safety/Efficacy of Diagnostic Skin Test Panel and Desensitization Hormone Kit for Treatment of Premenstrual Syndrome (PMS)

Conditions: Premenstrual Syndrome
NCT01260805

Completed

A Bioequivalence Study Of Ethinylestradiol + Gestodene In Female And Healthy Volunteers.

Conditions: Bioequivalence; Ethinylestradiol; Gestodene; Harmonet
NCT03949985

Active, not recruiting

Longitudinal Hemostatic Profile After Stopping Estroprogestative Contraceptives

Conditions: Venous Thromboembolism; Contraception
NCT02672826

Completed

Description of the Endothelial Phenotypes From the Subcutaneous Abdominal and Gluteo-femoral Adipose Tissues in Women

Conditions: Obesity
NCT04513405

Not yet recruiting

Estrogens Levels and Receptors Status and Skin Tears

Conditions: Skin Tear; Estrogen Deficiency
NCT00711607

Completed

A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2 (COMPLETED)(P05822)

Conditions: Healthy
NCT02892942

Unknown status

NATural Ovarian Stimulation

Conditions: Infertility
NCT01411644

Unknown status

Pheno- & Genotyping POF (WHO III)

Conditions: Premature Ovarian Failure (POF); Incipient Ovarian Failure; Poor Response After Ovarian Hyperstimulation; Early Menopause; Hypergonadotropic Amenorrhea
NCT00309855

Completed

Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men

Conditions: Aging
NCT01817400

Completed

Mediators of Abnormal Reproductive Function in Obesity (MARO)

Conditions: Infertility, Female; Obesity
NCT01175759

Unknown status

Role of Hypersensitivity to Female Sex Hormones in Women With Unexplained Recurrent Pregnancy Loss

Conditions: Abortion, Recurrent
NCT01089049

Completed

Effect of a Natural Health Product on Urinary Estrogen Metabolites

Conditions: Breast Cancer
NCT03018106

Terminated

Ospemifene vs. Conjugated Estrogens in the Treatment of Postmenopausal Sexual Dysfunction

Conditions: Sexual Dysfunction, Physiological
NCT00491595

Completed

Phase I Clinical Study of Soy Isoflavones in Healthy, Post-Menopausal Women

Conditions: Drug Toxicity
NCT04615767

Completed

D-chiro-inositol Increases Androgens and Reduces Estrogens in Human Serum

Conditions: Low Serum Testosterone Levels in Man
NCT00160342

Completed

Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot Flushes

Conditions: Hot Flushes, Menopause, Postmenopause
NCT00141557

Terminated

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal Women

Conditions: Menopause
NCT00141544

Terminated

The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal Women

Conditions: Menopause
NCT00522262

Completed

Alberta Physical Activity and Breast Cancer Prevention (ALPHA) Trial

Conditions: Breast Neoplasms